The Group has signed a technical agreement with Peking University to introduce its c-Myc inhibitor project
- Categories:The development course
- Author:
- Origin:
- Time of issue:2019-03-06 02:19
- Views:
(Summary description)
The Group has signed a technical agreement with Peking University to introduce its c-Myc inhibitor project
(Summary description)
- Categories:The development course
- Author:
- Origin:
- Time of issue:2019-03-06 02:19
- Views:
Information
It has completed Series D investment of approximtely USD45 million
Suzhou Kintor and CMAB Biopharma Inc. established strategic cooperation for the development and production of ALK-1 monoclonal antibody
The GT0486 (Detorsertib tablets) project has been approved for clinical trials in China
A phase II clinical trials of GT90001 (ALK-1 antibody) combined with PD-1 for liver cancer has been launched in Taiwan
The Group has signed a technical agreement with Peking University to in-license its c-Myc inhibitor project
Scan the QR code to read on your phone